The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
Insurers in the commercial sector and Medicare have traditionally had the authority to exclude an accelerated-approved drug from coverage if they deem the clinical trial evidence insufficient.
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...